Clinical Trials
5 trialsNCT07190300 2026-06-03
TulmiSTAR-02
Novartis
Phase 1/2 Recruiting
NCT03437941 2026-05-15
Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics
Phase 1/2 Terminated
NCT06764485 2026-05-06
rechARge
Celgene
Phase 3 Recruiting
NCT07336446 2026-05-01
ANDROMEDA
AstraZeneca
Phase 1/2 Recruiting
NCT02294461 2025-10-24
An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
Astellas Pharma Inc
Phase 3 Completed